---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-314591"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2026-07-23T21:15:56+00:00"
generated_at: "2026-07-23T21:18:04.403716+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Faeth Therapeutics grants performance options to employees; CEO receives 398,018 shares tied to $70 stock price hurdle

## Summary
- CEO Anand Parikh granted 398,018 performance-based stock options; exercise price equals grant-date closing price.
- Options vest in a single tranche when 30-day average closing price reaches $70.00 within 4 years, or upon change in control with ≥$70 per share consideration.
- General Counsel Christopher Gerry and SVP Finance Josiah Craver each received options (84,766 and 30,824, respectively); both no longer classified as executive officers as of June 2026.
- If the stock price hurdle is not met within the performance period or upon termination of service, all performance options are forfeited.

## SEC filing metadata
- accession: 0001193125-26-314591
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2026-07-23T21:15:56+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312526314591/0001193125-26-314591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312526314591/d68855d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-314591
- JSON: https://secwatch.observer/filing/0001193125-26-314591.json
- Plain text: https://secwatch.observer/filing/0001193125-26-314591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.